AI-generated summary
The authors describe a 71-year-old woman who developed diffuse gray-brown facial skin discoloration one week after starting latanoprost eye drops for glaucoma. She stopped latanoprost and received laser treatment with topical agents, and the authors report that her hyperpigmentation was effectively and safely treated after 10 weeks. This is a single case report.
- Participants
- 1
- Who or what was studied
- A single 71-year-old woman with glaucoma who developed diffuse facial hyperpigmentation while using latanoprost eye drops.
- Wavelengths
- 532, 1064 nm
- Limits stated in the abstract
- The report describes a single patient, so the findings cannot be generalized and the abstract does not establish that the treatment caused the improvement.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Fluence. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.